Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

ABSTRACT:

Background

Persons with chronic kidney disease (CKD) are at high risk for cardiovascular disease events, but are not classified as such in current US cholesterol treatment guidelines. We examined potential effects of modified guidelines in which CKD was considered a "coronary heart disease (CHD) risk equivalent" for risk stratification.

Study design

Nationally representative cross-sectional study.

Setting & participants

4,823 adults 20 years or older from the 2007-2010 National Health and Nutrition Examination Survey.

Predictors

Cardiovascular risk stratification based on current US cholesterol treatment guidelines and 2 simulated scenarios in which CKD stages 3-5 or CKD stages 1-5 were considered a CHD risk equivalent.

Outcomes & measurements

Proportion

SUBMITTER: Foster MC 

PROVIDER: S-EPMC3988260 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature